Status:
COMPLETED
Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Arthrogryposis Multiplex Congenita
AMC-Arthrogryposis Multiplex Congenita
Eligibility:
All Genders
Up to 18 years
Brief Summary
The aim of our study is to evaluate the correlation between quantified fibro-adipous infiltration of muscles on MRI assessed by MERCURI Score and the functional abilities (deficiencies, activity limit...
Detailed Description
Arthrogryposis multiplex congenita (AMC) is a group of rare diseases characterized by joint contractures at two or more distinct joint levels at birth. More than 400 causes are currently known. The pr...
Eligibility Criteria
Inclusion
- age \< 18 at the first clinical evaluation or follow up exclusively in CHUGA pediatric rehabilitation unit
- Clinical or molecular diagnosis of AMC established by geneticists at CHUGA
- functional evaluation during consultation and follow-up in CHUGA pediatric rehabilitation unit
- Muscle MRI of upper limbs, lower limbs and trunk performed at CHUGA pediatric radiology unit
Exclusion
- Contra indication MRI.
- MRI non exploitable.
- Patient under guardianship or deprived of liberty
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT05393375
Start Date
May 1 2022
End Date
November 1 2022
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
La Tronche, France, 38700